Improved Pharma https://validator.w3.org/feed/docs/rss2.html X-ray Powder Diffraction (XRPD) Meet Our Team Of Consultants Improved Pharma Expands Pharmaceutical Development Services with New Automated Dissolution Capabilities Improved Pharma Expands Footprint at Kurz Purdue Technology Center, Now Occupying Over 5,500 Square Feet Dissolution-Instrument-Based Strategies to De-Risk and Accelerate Pharmaceutical Development Improved Pharma Announces Enhanced X-Ray Diffraction and Interpretation Services to Strengthen Market Authorization Applications and Patents New Edition of Seminal Text “Solid-State Materials in Pharmaceutical Chemistry” Released by Industry Leaders Improved Pharma initiates research and development program Reduced Dose Formulations Publication of Crystal Structure of Ritonavir Form IV and Thermodynamic Relationships between Ritonavir Polymorphs Process and Method Validation in IND Drug Development: Building a Robust Foundation Home Improved Pharma continues growth adding microscopy laboratory in 2024 Detection of low-level solid form impurities Pharmaceutical and Regulatory Issues Co-processed Pharmaceutical Solids – An Approach to Screening by Steve Byrn Improved Pharma Announces New Scanning Electron Microscopy (SEM) Capabilities in Collaboration with Chemical Microscopy, LLC. Seeing Solids Clearly—Beyond Powder Patterns with Single-Crystal X-ray Diffraction for Polymorphs, Hydrates, and IP Confidence: How Improved Pharma Uses SCXRD Registration now open for Spring Pharmaceutical Synchrotron XRPD Workshop Improved Pharma Enhances Thermal Characterization Suite with Discovery DSC 25 Analytical Methods for Studying Co-processed Pharmaceutical Solids – By Steve Byrn Joint research collaboration between Merck, Purdue University, Argonne National Laboratory, and Improved Pharma Analytical Testing Services Liquid Chromatography – Mass Spectrometry (LC-MS) Zetasizer Solid State Chemistry of Long-Acting Injectable Suspensions Improved Pharma exhibiting and presenting at AAPS 2025 PHARMSCI 360 Improved Pharma announces onsite demonstration of micromanipulator for precision microscopy News and Publications Improved Pharma exhibiting and presenting posters at AAPS 2024 PHARMSCI 360 Pharmaceutical and Regulatory Problem-Solving Improved Pharma Announces New High-Resolution Accurate Mass Spectrometry (LC-HRAMS) Capabilities (SCIEX 6600 TripleTOF) Improved Pharma announces new collaboration with Videra Advisors, LLC to expand pharmaceutical development services Improved Pharma Expands In-House Single Crystal Capabilities Using Optical Microscopy, Hot Stage Microscopy, and DSC Microscopy for Co-Processing Strategies – By Steve Byrn and Dale Purcell Report on Benmore-Wilke Method for Structure Determination of Co-Processed ASD Report on Co-Processing Plenary Lectures at the SPS-XRPD-4 Workshop Achieving Control in IND Drug Development: Improved Pharma’s Comprehensive Strategy About Book: Solid State Properties of Pharmaceutical Materials Improved Pharma Adds UHPLC Capabilities to Service Offerings Scanning Electron Microscopy The High-Quality Difference: Solid-State Data That Stands Up to FDA and Patent Review Improved Pharma presenting at AAPS 2022 PHARMSCI 360 with Rapid Fire Presentation and Posters Ritonavir research selected as a top “Remarkable Accomplishment” Improved Pharma at AAPS 2023 PHARMSCI 360 with booth #3323, two posters, and an invited talk as a Speaker Spotlight Joint research collaboration with Chemical Microscopy, LLC featured in the “Improving Product Quality & Material Understanding” special issue of Pharmaceutical Research Mission success: Ritonavir crystallization experiments conducted in space worked flawlessly Single Crystal X-Ray Structure Determination Improved Pharma announces addition of John Torchia to the team